Veno-arterial extracorporeal membrane oxygenation for drug intoxications: A single center, 14-year experience - Archive ouverte HAL Access content directly
Journal Articles Journal of Cardiac Surgery Year : 2022

Veno-arterial extracorporeal membrane oxygenation for drug intoxications: A single center, 14-year experience

(1, 2) , (1) , (1) , (1) , (1) , (3, 1) , (4, 5) , (1) , (1) , (3, 1)
1
2
3
4
5

Abstract

BACKGROUND AND AIM OF THE STUDY: Acute cardiovascular failure remains a leading cause of death in severe poisonings. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been increasingly used as a rescue therapeutic option for those cases refractory to optimal conventional treatment. We sought to evaluate the outcomes after VA-ECMO used for drug intoxications in a single-center experience. METHODS: We performed an observational analysis of our prospective institutional database. The primary endpoint was survival to hospital discharge. RESULTS: Between January 2007 and December 2020, 32 patients (mean age: 45.4 ± 15.8 years; 62.5% female) received VA-ECMO for drug intoxication-induced refractory cardiogenic shock (n = 25) or cardiac arrest (n = 7). Seven (21.8%) patients developed lower limb ischemia during VA-ECMO support. Twenty-six (81.2%) patients were successfully weaned after a mean VA-ECMO support of 2.9 ± 1.3 days. One (3.1%) patient died after VA-ECMO weaning for multiorgan failure and survival to hospital discharge was 78.1% (n = 25). In-hospital survivors were discharged from hospital with a good neurological status. Survival to hospital discharge was not statistically different according to sex (male = 75.0% vs. female = 80.0%; p = .535), type of intoxication (single drug = 81.8% vs. multiple drugs = 76.1%; p = .544) and location of VA-ECMO implantation (within our center = 75% vs. peripheral hospital using our Mobile Unit of Mechanical Circulatory Support = 100%; p = .352). Survival to hospital discharge was significantly lower in patients receiving VA-ECMO during on-going cardiopulmonary resuscitation (42.8% vs. 88.0%; p = .026). CONCLUSIONS: VA-ECMO appears to be a feasible therapeutic option with a satisfactory survival rate and acceptable complications rate in poisonings complicated by refractory cardiogenic shock or cardiac arrest.
Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

inserm-03755431 , version 1 (22-08-2022)

Identifiers

Cite

M. Pozzi, R. Buzzi, A. Hayek, P. Portran, R. Schweizer, et al.. Veno-arterial extracorporeal membrane oxygenation for drug intoxications: A single center, 14-year experience. Journal of Cardiac Surgery, 2022, 37 (6), pp.1512-1519. ⟨10.1111/jocs.16456⟩. ⟨inserm-03755431⟩
12 View
8 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More